drugset / Trial / NCT01106053

Pramipexole for Binge Eating Disorder

NCT01106053

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is being conducted to evaluate the effects that the drug pramipexole has on mood, food craving, and other behaviors that may be related to binge eating disorder.

Timeline

Start
2010-04
Primary completion
2011-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Pramipexole Unknown 0.5 mg

Indications